Latest News

  • All
  • Events
  • Insights
  • Interviews
  • News
  • Newsletter
  • Reports
More

    Editor's Picks

    • All
    • Events
    • Insights
    • Interviews
    • News
    • Newsletter
    • Reports
    More

      Reports

      • All
      • Events
      • Insights
      • Interviews
      • News
      • Newsletter
      • Reports
      More
        Load More

        Must Read

        • All
        • Events
        • Insights
        • Interviews
        • News
        • Newsletter
        • Reports
        More

          Quick Takeaways:  Why It Matters?  Cronus Pharma’s launch of Robenacoxib Injection gives US veterinarians the first FDA‑approved bioequivalent to Onsior (robenacoxib) Injection, providing a cost‑effective, short‑term NSAID option for postoperative pain and inflammation in dogs (soft‑tissue surgery) and cats (orthopedic surgery, OHE, castration) ≥4 months, for up to 3 days. 1139 As a 20 mg/mL, 20 mL multidose vial distributed nationally,...